- Villalva, Marisol
- García-Díez, Esther
- López de las Hazas, María-Carmen
- Iacono, Oreste Lo
- Vicente-Díez, Ignacio
- García-Cabrera, Sara
- Alonso-Bernáldez, Marta
- Dávalos, Alberto
- Martín, M. Ángeles
- Ramos, Sonia
- Pérez-Jiménez, Jara
Postprandial metabolic disturbances are exacerbated in type 2 diabetes (T2D). Cocoa and carob, despite showing promising effects on these alterations in preclinical studies, have not yet been jointly tested in a clinical trial. Therefore, this acute, randomised, controlled, crossover nutritional trial evaluated the postprandial effects of a cocoa-carob blend (CCB) in participants with T2D (n = 20) and overweight/obesity. The subjects followed three treatments: hypercaloric breakfast (high-sugar and high-saturated fat, 900 kcal) as the control (treatment C); the same breakfast together with 10 g of the CCB, with 5.6 g of dietary fibre and 1.6 g of total polyphenols (treatment A); and the same breakfast after consuming the CCB (10 g) the night before (treatment B). Various analyses were performed, including the determination of the clinical markers of T2D (fasting and postprandial glucose and insulin, GLP-1, and glycaemic profile), satiety evaluation, analysis of exosomal miRNA expression and ex vivo determination of inflammation modulation. No effect on glucose homeostasis (glucose, insulin, and GLP-1) was found in the study population. However, eight exosomal miRNAs were found to be significantly modified owing to CCB supplementation compared with treatment C, with three of them (miR-20A-5p, miR-23A-3p, and miR-17-5p) associated with an improvement in insulin sensitivity. Furthermore, the CCB caused a decrease in hunger feelings (0-120 min), as assessed by the visual analogue scale (VAS). Finally, treatment A caused a significant decrease in the glucose increment within 0-30 min of treatment in subjects with overweight. No significant modifications were found in the other assessed parameters. The acute intake of the CCB by subjects with T2D showed modest although significant results, which need to be validated in a long-term randomised controlled trial., This work was supported by the grant RTI2018-095059-B-I00, funded by MCIN/AEI/10.13039/501100011033/ and “ERDF A way of making Europe”. The study was partially funded by TED2021-130962B-C21 and financed by MICIU/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR. None of the funders were involved in the assessment and interpretation of the data or in manuscript preparation. E. G.-D. was the recipient of a contract from Comunidad de Madrid (PEJ-2020-AI/BIO-18529). M. V. was the recipient of a postdoctoral contract “Margarita Salas” (Plan de Recuperación, Transformación y Resiliencia) from the Spanish Ministry of Universities and Madrid Autonomous University (CA1/RSUE/2021-00588). MCLH is a recipient of of a Ramon y Cajal Grant RYC2022-037626-I, MCIU/AEI/10.13039/501100011033 and FSE+. CIBEROBN (CB22/03/00068) and CIBERDEM (CB/07/08/0013) are initiatives of the Instituto de Salud Carlos III, Spain. Ms M. Nogués Cañadas, Mr I. Escudero Abad and Ms. M. Renard are thanked for technical assistance. Ms Macarena Paredes-López, from Siemens, provided technical support during abdominal echographia and transient elastography assessments., Peer reviewed